Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for medical industry professionals · Friday, April 19, 2024 · 704,981,772 Articles · 3+ Million Readers

Supreme Cannabis Focused on Disciplined Deployment of Capital -- CFN Media

SEATTLE, Nov. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Supreme Cannabis Co. (TSX-V: FIRE) (OTCQX: SPRWF).

The cannabis industry has boomed in recent years supported by the access to inexpensive capital, which has stemmed from a voracious investor appetite for cannabis exposure and the prospects of outsized returns. In turn, many licensed producers have quickly deployed any raised capital to feed the investor frenzy and the demand for growth prospects and transactions without necessarily looking at the long-run and the need to maximize return on capital.

There are a few exceptions to this, and the Supreme Cannabis Co. is an issuer that has taken a disciplined approach with a focus on maximizing shareholder value over the long-run by ensuring prudent capital management and allocation.

Utilizing Product Experts in a Segmenting Market

A recent clear example of Supreme’s strategy can be found in its approach to cannabis extract production. Cannabis oils have had a significant share of the medical cannabis market, according to Health Canada. As such, it is not surprising that many licensed producers have invested significant capital in building out large extraction facilities to produce cannabis oils. Dedicating capital to this function is a calculated risk with a rapidly evolving market and international opportunities on the horizon that might require this capital.        

Supreme Cannabis has generally taken a contrarian view in its approach to the market. In the case of domestic cannabis oil extraction, Supreme Cannabis has not deployed capital to build domestic oil facilities. Instead, the company has operated on the thesis that as the cannabis market evolved it would naturally segment, and dedicated product experts would be established. This is the same trend the company has observed in mature US markets.  

Supreme’s thesis played out correctly as dedicated extraction companies such as MediPharm Labs Corp. and Neptune Wellness Solutions Inc. have come to market. The company recently signed a deal with MediPharm to produce Supreme’s first line of cannabis oils. Supreme will provide an initial 1,000 kilograms of dried cannabis flower that will be converted into approximately 200,000 40ml tinctures in the first year. The agreement runs for three years, and the initial amounts constitute minimum annual production levels which can be increased as needed. Canopy Growth also has taken advantage of these experts – supplementing its extraction capabilities with an agreement with Neptune.

This agreement provides Supreme with the same cannabis oil market exposure as its peers with none of the capital costs and associated risks – allowing the company to deploy capital in other opportunities.   

Supreme Cannabis Becomes Sixth Largest Canadian LP by Revenues

Supreme Cannabis Co.’s revenue rose 229 percent to $5.14 million during its first quarter of fiscal 2019 (calendar Q3). These results are driven by a growing number of supply agreements with other licensed producers and deals with six provinces to supply recreational cannabis to consumers.

At an annual revenue run rate of $20.6M, these results rank Supreme sixth among the Canadian LPs: 1) Aurora Cannabis has a revenue run rate of $118M, 2) Canopy Growth at $93M, 3) Aphria at $53M, 4) Tilray Inc. at $52M, and 5) CannTrust at $50.35M. It is noteworthy that every single one of the LPs listed above trades a significant valuation premium to Supreme Cannabis, as well as several companies with lower reported revenues.  

Looking Ahead

The Supreme Cannabis Co. (TSX-V: FIRE) (OTCQX: SPRWF) represents a compelling investment opportunity in the burgeoning cannabis industry. With its disciplined approach to the market, the company is laser-focused on generating high rates of return on its deployed capital and ultimately building significant long-term shareholder value.

For more information, visit the company’s website or download its investor presentation.

Please follow the link to read the full article: http://www.cannabisfn.com/supreme-cannabis-focused-disciplined-deployment-capital/

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

About CFN Media

CFN Media (CannabisFN) is the leading agency and financial media network dedicated to the global cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Since 2013, private and public cannabis companies in the US and Canada have relied on CFN Media to grow and succeed.

Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on http://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.  

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

Frank Lane
206-369-7050
Flane@cannabisfn.com

cfn_tweakedspacing.jpg

Powered by EIN News
Distribution channels: Healthcare & Pharmaceuticals Industry


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release